Eculizumab in thymoma-associated myasthenia gravis: a real-world cohort study

Eculizumab in thymoma-associated myasthenia gravis: a real-world cohort study

Background: Thymoma-associated myasthenia gravis (TAMG) is a subtype of myasthenia gravis (MG) that is associated with more severe symptoms and a relatively poor prognosis. Eculizumab, an inhibitor to target human C5 component of the complement cascade, is considered a treatment option for refractor...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид: Lei Jin, Dingxian He, Quantao Zeng, Song Tan, Jianquan Shi, Ying Liu, Zhangyu Zou, Jie Song, Chong Yan, Xiao Huan, Yuan Wang, Lei Yang, Jianying Xi, Zongtai Wu, Ziqi Liu, Jianming Zheng, Chongbo Zhao, Xianglin Chu, Sushan Luo
Формат: Өгүүллэг
Хэл сонгох:English
Хэвлэсэн: SAGE Publishing 2024-12-01
Цуврал:Therapeutic Advances in Neurological Disorders
Онлайн хандалт:https://doi.org/10.1177/17562864241309431

Интернэт

https://doi.org/10.1177/17562864241309431

Ижил төстэй зүйлс